Statement Of Cash Flows [Abstract]

Biocartis Group NV - Filing #3123157

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
8,411,000 EUR
15,768,000 EUR
Adjustments for decrease (increase) in trade and other receivables
5,916,000 EUR
1,449,000 EUR
Adjustments for increase (decrease) in trade and other payables
1,489,000 EUR
6,333,000 EUR
Adjustments for increase (decrease) in employee benefit liabilities
69,000 EUR
323,000 EUR
Adjustments for undistributed profits of investments accounted for using equity method
659,000 EUR
532,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.